Advances in Low-Concentration Atropine and Optical Interventions for Myopia Control
Advances in World Medical Research · 2026
DOI: 10.71204/h4ject27 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in World Medical Research, 2026. Verfasst von Weixing Xu und 1 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myopia has become a global public health challenge, with its prevalence reaching epidemic proportions in recent decades, particularly in East Asian countries. This comprehensive review synthesizes recent evidence from clinical studies and meta-analyses to examine the efficacy and safety of low-concentration atropine and optical interventions for controlling myopia progression in children and adolescents. We show that low-concentration atropine (specifically 0.01%, 0.025%, and 0.05%) effectively slows myopia progression with a favorable safety profile. Furthermore, we evaluate optical interventions including orthokeratology (Ortho-K), Defocus Incorporated Multiple Segments (DIMS) spectacles, and peripheral progressive addition lenses. Emerging evidence suggests that combination therapy, integrating low-concentration atropine with an optical intervention, may yield superior effects compared to either modality alone. This review also discusses key issues such as treatment personalization, long-term adherence, and future research directions, providing evidence-based insights for clinicians managing childhood myopia.
Zitieren
APA
Xu, W., & Zhang, Y. (2026). Advances in Low-Concentration Atropine and Optical Interventions for Myopia Control. Advances in World Medical Research. https://doi.org/10.71204/h4ject27
Vancouver
Xu W, Zhang Y. Advances in Low-Concentration Atropine and Optical Interventions for Myopia Control. Advances in World Medical Research. 2026. doi:10.71204/h4ject27
BibTeX
@article{Xu2026,
author = {Xu, Weixing and Zhang, Yan},
title = {Advances in Low-Concentration Atropine and Optical Interventions for Myopia Control},
journal = {Advances in World Medical Research},
year = {2026},
doi = {10.71204/h4ject27}
}
EUVIMED